BioNTech
BNTX
$86.71
Share price
-1.57%
Change (1 day)
-25.84%
Change (1 year)
Revenue for BioNTech (BNTX)
Revenue in 2023 (TTM): $4.15 B
According to BioNTech's latest financial reports the company's current revenue (TTM) is $4.15 B. In 2022 the company made a revenue of $18.43 B a decrease over the years 2021 revenue that were of $22.04 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BioNTech from 2019 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $4.15 B | -77.46% |
| 2022 | $18.43 B | -16.37% |
| 2021 | $22.04 B | 3690.79% |
| 2020 | $0.58 B | 379.17% |
| 2019 | $0.12 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |